While I can't confirm that FBI and OIG are cold calling current and former employees I can confirm that authorities were contacted regarding organized sales tactics that were primarily centered around "the spread" and how much money an office could profit from infusing Reclast. In addition, much documentation was submitted to home office by field staff alerting Novartis of several large practices and clinics that were buying Reclast from Canada(cheaper) and submitting for reimbursement under U.S. Medicare pricing in order to maximize their revenue. Home office allowed this to happen for fear that they would lose the revenue of 30ish vials a month per office in two dozen or so offices. The fear that these locations would stop writing Novartis products altogether once the law became involved was in itself enough for the company to decide to turn a blind eye as we are literally talking about THOUSANDS of scripts. Wait and see my friends this is going to get nasty.